Hoff, F. W., Huang, Y., Welkie, R. L., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Zeidner, J. F., Olin, R. L., Smith, C. C., Schiller, G. J., Curran, E. K., Handa, S. V., Heerema, N. A., Chen, T., Martycz, M., Stefanos, M., Marcus, S. G., Rosenberg, L., Druker, B. J., Levine, R. L., Burd, A., Yocum, A. O., Borate, U. M., Mims, A. S., Byrd, J. C. and Madanat, Y. F. (2020) “<i>IDH2</i&gt; mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.288743.